Osteoclasts intercept meningeal lymphatic paths for dural metastasis.

Osteoclasts disrupt meningeal lymphatic drainage in dural metastasis, with significant impairment linked to tumor progression in a mouse model.

• Why it matters: Dural metastasis from cancers like breast and lung presents unique clinical challenges, partly due to poorly understood mechanisms involving lymphatic dysfunction, which this study aims to clarify.
• What they did: Researchers used a new mouse model and single-cell RNA sequencing to analyze tumor microenvironments, identifying osteoclast-driven immunosuppression and lymphatic disruption, and tested osteoclast-targeting therapies.
• The result: Targeting osteoclasts restored lymphatic function and enhanced anti-tumor immune responses, suggesting a promising therapeutic strategy to improve outcomes for patients with dural metastasis.